The rising interest in successful weight management has led to considerable research into cutting-edge treatments. Recently , Retatrutide, a twin-action GIP and glucagon-like peptide-1 (GLP-1) receptor activator , has exhibited promising results in patient trials, suggesting potential for significant weight loss . Consequently , several individuals